Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
Adenovirus vectored vaccines have entered global use during the COVID-19 pandemic, and are in development for multiple other human and veterinary applications. An attraction of the technology is the suitability of the vaccines for storage at 2–8 °C for months. Widely used COVID-19 vaccine ChAdOx1 nC...
Main Authors: | Adam Berg, Daniel Wright, Pawan Dulal, Anna Stedman, Sofiya Fedosyuk, Michael J. Francis, Bryan Charleston, George M. Warimwe, Alexander D. Douglas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/11/1249 |
Similar Items
-
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
by: Zhang, C, et al.
Published: (2023) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
by: Cheng Zhang, et al.
Published: (2023-06-01) -
Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
by: Lea Krutzke, et al.
Published: (2022-07-01) -
Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01) -
DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
by: Gerardo Casucci, et al.
Published: (2021-06-01)